Citius Pharmaceuticals (CTXR) Proxy Filing summary

Executive summary

• Annual meeting scheduled for March 10, 2025, at company headquarters in Cranford, NJ.

• Shareholders can vote online, by mail, or in person, with voting open until March 9, 2025.

• Proxy materials and annual report are available online or by request before February 24, 2025.

Voting matters and shareholder proposals

• Election of seven directors to serve until the 2026 annual meeting.

• Advisory vote to approve executive compensation.

• Proposal to amend Articles of Incorporation to increase authorized shares from 26M to 260M and common shares from 16M to 250M.

• Ratification of Wolf & Company, P.C. as independent auditor for fiscal year ending September 30, 2025.

• Approval to adjourn the meeting if more time is needed for proxy solicitation.

Board of directors and corporate governance

• Seven nominees listed for board election, including Myron Holubiak, Leonard Mazur, Suren Dutia, Carol Webb, Dr. Eugene Holuka, Dennis M. McGrath, and Robert Smith.